Familial Chylomicronemia
5 clinical trials · Condition
◉ Watch Familial Chylomicronemia
| Record | Firm | Date |
|---|---|---|
| Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) (NCT05089084) | Arrowhead Pharmaceuticals | 2021-12-14 |
| Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS) (NCT03783377) | Arrowhead Pharmaceuticals | 2019-03-08 |
| Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS (NCT06796426) | Arrowhead Pharmaceuticals | |
| Volanesorsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS) (NCT03544060) | Akcea Therapeutics |
Track Familial Chylomicronemia automatically
Every clearance here is in the API, with alerts when new ones post.